Table 3 Socio-demographic and disease characteristics of study participants
From: Patient preferences in allergy immunotherapy (AIT) in Germany – a discrete-choice-experiment
Gender | Number | Percentage | ||
|---|---|---|---|---|
Valid | 239 | 100 % | ||
Male | 101 | 42 % | ||
Female | 138 | 58 % | ||
Age (yrs.) | ||||
Valid | 239 | 100 % | ||
18–30 | 88 | 37 % | ||
31–45 | 77 | 32 % | ||
46–60 | 53 | 22 % | ||
>60 | 21 | 9 % | ||
Education | ||||
Valid | 233 | 100 % | ||
Lower or general education | 96 | 41 % | ||
Higher education | 137 | 59 % | ||
Children <14 years in household | ||||
Valid | 229 | 100 % | ||
No | 171 | 75 % | ||
Yes | 58 | 25 % | ||
Currently employed | ||||
Valid | 234 | 100 % | ||
No | 51 | 22 % | ||
Yes | 183 | 78 % | ||
Full-time | 138 | 75 % | ||
Part-time | 36 | 20 % | ||
Other | 6 | 3 % | ||
Missing | 3 | 2 % | ||
Type of allergy | ||||
Valid | 239 | 100 % | ||
Birch (of those birch only) | 126 (37) | 53 % (29 %) | ||
Grass pollen (of those grass pollen only) | 158 (50) | 66 % (32 %) | ||
House dust mite (of those house dust mite only) | 91 (33) | 38 % (36 %) | ||
Severity of nasal symptoms (assessed by patient) | ||||
Valid | 229 | 100 % | ||
VAS 0–49 | 30 | 13 % | ||
VAS 50–100 | 199 | 87 % | ||
VAS average | 72 | |||
Severity of symptoms affecting the eyes (assessed by patient) | ||||
Valid | 227 | 100 % | ||
VAS 0–49 | 75 | 33 % | ||
VAS 50–100 | 152 | 67 % | ||
VAS average | 57 | |||